Latest Breaking News On - Prof matt whiteman - Page 2 : comparemela.com

- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing.

United kingdomOliver sextonJon reesDaniel goochHideo kimuraHarwell oxfordMatt whitemanSanyo onoda city universityScience angel syndicate networkUnited kingdom innovation science seed fundFink family officeMedia contact scius communicationsUniversity of exeterCompany contact mitorxOxford technology managementAppoints industry veteran glyn edwards